Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.
Brask-Lindemann, D
Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Jun 2013 - 1891-7 p. digital
Publication Type: Journal Article
1433-2965
10.1007/s00198-012-2220-6 doi
Aged
Alendronate--administration & dosage
Bone Density Conservation Agents--administration & dosage
Case-Control Studies
Denmark
Drug Prescriptions--statistics & numerical data
Drug Utilization--statistics & numerical data
Female
Glucocorticoids--adverse effects
Humans
Middle Aged
Osteoporosis, Postmenopausal--etiology
Practice Patterns, Physicians'--statistics & numerical data
Pulmonary Disease, Chronic Obstructive--complications
Registries
Risk Factors
Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Jun 2013 - 1891-7 p. digital
Publication Type: Journal Article
1433-2965
10.1007/s00198-012-2220-6 doi
Aged
Alendronate--administration & dosage
Bone Density Conservation Agents--administration & dosage
Case-Control Studies
Denmark
Drug Prescriptions--statistics & numerical data
Drug Utilization--statistics & numerical data
Female
Glucocorticoids--adverse effects
Humans
Middle Aged
Osteoporosis, Postmenopausal--etiology
Practice Patterns, Physicians'--statistics & numerical data
Pulmonary Disease, Chronic Obstructive--complications
Registries
Risk Factors